What is it about?
N-butyl cyanoacrylate (NBCA) has been used to embolise brain arteriovenous malformations (AVMs) for over 30 years. It is a mixed with lipiodol in varying proportions. We report a case of AVM, which was successfully embolized using a 20% NBCA and lipiodol mixture. The lipiodol in the NBCA migrated into the ventricles after the thin part of the wall ruptured 5 days after the embolization.
Featured Image
Why is it important?
We report a temporal AVM with intranidal aneurysm that was successfully embolized using a 20% mixture of NBCA and lipiodol, with confirmed migration of lipiodol into the lateral ventricles on CT 5 days after embolization. It is rare complication after embolization of AVM.
Perspectives
We presented a rare complication of embolization of AVM using a mixture of NBCA and lipiodol. This rare complication can occur, if you embolise AVM with the standard technique.
Mamoru Murakami
Kyoto Daini Red Cross Hospital
Read the Original
This page is a summary of: Migration of lipiodol into lateral ventricles after embolization of cerebral arteriovenous malformation: a case report, British Journal of Neurosurgery, July 2019, Taylor & Francis,
DOI: 10.1080/02688697.2019.1648755.
You can read the full text:
Contributors
The following have contributed to this page
